Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial
Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that "compare favourably'' with the two mRNA vaccines already on the market from Pfizer and Moderna.